SPL
Click for more information
7.14% 10.5¢ starpharma holdings limited

ASCO Presentations 2024, page-24

  1. peony-rose
    2,835 Posts.
    lightbulb Created with Sketch. 138
    clock Created with Sketch.
    29/04/24
    16:25
    Post #: 73563324
    Or could it be that someone is waiting for the results of Dep Irinotecan phase 2 - then the Dep trio might have much more interest. Possibly waiting to license out the trio together?
    SPL Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢ 		Change
0.007(7.14%) 		Mkt cap ! $43.29M
Open High Low Value Volume
9.5¢ 10.5¢ 9.5¢ $8.154K 83.09K

Buyers (Bids)

No. Vol. Price($)
1 5102 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 124847 3
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.